Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
Go back to Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri| (NASDAQ: PCSA) | Delayed: 2.22 +0.04 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $ | |||
| Open | $2.18 | 52 Week Low | $ | |||
| Day High | $2.22 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $ | |||
| Volume | 4,365 | |||||
